HOME >> BIOLOGY >> NEWS
Researchers identify cells that make relapse inevitable in acute lymphoblastic leukemia

Prague, Czech Republic: In "Dr Jekyll and Mr Hyde" Robert Louis Stevenson wrote about the good and evil sides of the same person; now scientists in Australia have discovered that in acute lymphoblastic leukaemia (ALL) there are Dr Jekyll and Mr Hyde cells "good" and "evil" clones of the same type of ALL cell.

The "evil" cells are clones that have a pre-existing, rather than acquired, resistance to drugs used for treating ALL, and their presence in a patient means that person will inevitably relapse after chemotherapy, however well they respond initially.

The discovery means that now researchers may be able to design therapies that will specifically target these resistant subclones so that, in the future, patients who have been identified as having them can be treated immediately with the alternative therapies.

ALL is the most common cancer in children and, although nearly all patients will respond initially to chemotherapy, one in four will relapse. Seoyeon Choi told the EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Prague today (Thursday 9 November): "We have previously shown that these relapses were due to small numbers of surviving and highly drug refractory cells. However, until now, it has been unclear whether these relapses resulted from the acquisition of therapy-induced drug resistance or were caused by a subpopulation of cells that were already intrinsically drug resistant."

Ms Choi, a final year PhD student at the Children's Cancer Institute Australia in Sydney and medical student at the University of Sydney, Australia, analysed samples taken from 25 ALL patients at the time of their diagnosis and at their relapse to discover the molecular "fingerprint" of every ALL cell.

"White blood cells, or lymphocytes, are unique in that every one has its own molecular signature. Therefore, we can 'molecular fingerprint' each lymphocyte in order to know what the leukaemia 'looks' l
'"/>

Contact: Emma Mason
wordmason@mac.com
44-077-112-96986
European Organisation for Research and Treatment of Cancer
9-Nov-2006


Page: 1 2 3

Related biology news :

1. Researchers find pathway that controls cell size and division
2. Researchers watch antibiotics, bacteria meet at atomic level
3. Researchers discover gene responsible for Restless Legs Syndrome
4. Researchers witness natural selection at work in dramatic comeback of male butterflies
5. Researchers discover human embryonic stem cells are the ultimate perpetual fuel cell
6. Researchers use new approach to predict protein function
7. Researchers probe risks, benefits of folic acid fortification
8. Researchers identify genetic mutation that may alter tumor cell proliferation
9. Researchers discover method for identifying how cancer evades the immune system
10. Researchers use adult stem cells to create soft tissue
11. Researchers find gene that spurs development of the epididymis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/5/2019)... Calif. (PRWEB) , ... July 05, 2019 , ... ... with Microsoft to bring its patented Tractus™ Platform to governments around the world. ... bring cutting edge technology and point of care solutions to operating theatres worldwide ...
(Date:6/19/2019)... LAS VEGAS (PRWEB) , ... June 19, 2019 , ... ... on improving physicochemical properties of Cefazolin Sodium, antibiotic which can prove to be beneficial ... Over 519% increase in residue amount , Over 68% decrease in ...
(Date:6/13/2019)... ... June 13, 2019 , ... KICVentures announced today its ... Spine, Orthopedic and Pain Management-Driven ASC Conference in Chicago on Thursday, June 13th at ... Wacker Dr. Chicago, IL in the 3rd floor Ticino Hospitality room in space #74T. ...
Breaking Biology News(10 mins):
(Date:5/7/2019)... ... May 06, 2019 , ... "The ... growing number of repositories being asked to store cellular products being used ... of contributors who are world leaders, who have shared their expertise in building ...
(Date:5/4/2019)... BROOK, N.J. (PRWEB) , ... May 03, 2019 ... ... electrophysiology, announces the release of the Diopsys® ffERG/Photopic Negative Response vision ... of glaucoma. , By 2050, it is estimated that 6.3 million Americans will ...
(Date:5/2/2019)... ... April 30, 2019 , ... The centuries old practice of ... breweries to local craft breweries, and even home brewing clubs scattered across the nation. ... biological processes, that when mastered can produce a superb product. Students at South ...
(Date:5/2/2019)... Calif. (PRWEB) , ... May 02, 2019 , ... ... clinical genetics testing company, will present results documenting discrepancies between U.S. insurer policies ... guidelines for patients at risk for hereditary breast and ovarian cancer (HBOC). ...
Breaking Biology Technology:
Cached News: